These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23708677)

  • 1. Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand.
    Sineath RC; Finneran C; Sullivan P; Sanchez T; Smith DK; Griensven Fv; Wimonsate W; Stephenson R
    J Int Assoc Provid AIDS Care; 2013; 12(4):227-31. PubMed ID: 23708677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.
    Tangmunkongvorakul A; Chariyalertsak S; Amico KR; Saokhieo P; Wannalak V; Sangangamsakun T; Goicochea P; Grant R
    AIDS Care; 2013 Aug; 25(8):961-7. PubMed ID: 23252473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of PrEP for HIV slow among MSM.
    Kirby T; Thornber-Dunwell M
    Lancet; 2014 Feb; 383(9915):399-400. PubMed ID: 24494225
    [No Abstract]   [Full Text] [Related]  

  • 4. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
    Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M
    BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
    JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.
    Karris MY; Beekmann SE; Mehta SR; Anderson CM; Polgreen PM
    Clin Infect Dis; 2014 Mar; 58(5):704-12. PubMed ID: 24319083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
    Blackwell CW
    Nurse Pract; 2014 Sep; 39(9):50-3. PubMed ID: 25140852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
    AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
    Marcus U
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():42-4. PubMed ID: 23961656
    [No Abstract]   [Full Text] [Related]  

  • 11. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.
    Mimiaga MJ; Case P; Johnson CV; Safren SA; Mayer KH
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):77-83. PubMed ID: 19295337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
    Van der Elst EM; Mbogua J; Operario D; Mutua G; Kuo C; Mugo P; Kanungi J; Singh S; Haberer J; Priddy F; Sanders EJ
    AIDS Behav; 2013 Jul; 17(6):2162-72. PubMed ID: 23080358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I Am Men's Health: Generating Adherence to HIV Pre-Exposure Prophylaxis (PrEP) in Young Men of Color Who Have Sex with Men.
    Daughtridge GW; Conyngham SC; Ramirez N; Koenig HC
    J Int Assoc Provid AIDS Care; 2015; 14(2):103-7. PubMed ID: 25331226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piloting a partially self-financed mode of human immunodeficiency virus pre-exposure prophylaxis delivery for men who have sex with men in Hong Kong.
    Lee SS; Kwan TH; Wong NS; Lee KCK; Chan DPC; Lam TTN; Lui GCY
    Hong Kong Med J; 2019 Oct; 25(5):382-391. PubMed ID: 31619578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.
    Sachdev DD; Stojanovski K; Liu AY; Buchbinder SP; Macalino GE
    Clin Infect Dis; 2014 Jun; 58(12):1786-7. PubMed ID: 24729556
    [No Abstract]   [Full Text] [Related]  

  • 16. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.
    Chang HH; Kim SW; Jung H; Lee SA; Park HK; Kim S; Lee JM; Choi JY
    J Korean Med Sci; 2018 Mar; 33(12):e91. PubMed ID: 29542300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.
    Fuchs JD; Sobieszczyk ME; Madenwald T; Grove D; Karuna ST; Andrasik M; Sherwat A; Broder G; Mayer K; Koblin B; Hammer S;
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):259-62. PubMed ID: 23614998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(23):463-5. PubMed ID: 23760186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.